Skip to main content

Table 3 School-age children: The importance of each outcome listed in the phase 2 questionnaire, as scored by clinicians and parents

From: Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people

  Clinicians (n = 43)    Parents (n = 27)   
Outcome Rank ( n /17) Median (IQR) Number (%) scoring outcome in top 3 Rank Median (IQR) Number (%) scoring outcome in top 3
Quality of Life 1 4 (3, 4) 20 (47) 2 4 (4, 4) 9 (33)
Exacerbations 2 4 (4, 4) 18 (42) 3 4 (4, 4) 9 (33)
Nocturnal symptoms 3 4 (4, 4) 16 (37) 4 4 (4, 4) 8 (30)
Normal activities 4 4 (4, 4) 12 (28) 8= 4 (4, 4) 4 (15)
Daytime symptoms 5 4 (4, 4) 11 (26) 6 4 (4, 4) 6 (22)
Death 6 4 (2, 4) 11 (26) 1 4 (4, 4) 14 (52)
Use of reliever inhaler 7 4 (3, 4) 9 (21) 10 4 (3, 4) 3 (11)
Hospital admission 8 4 (3, 4) 8 (19) 12 4 (4, 4) 2 (7)
Activity or exercise 9 4 (3, 4) 7 (16) 5 4 (3, 4) 7 (26)
Long-term adverse effect 10 4 (4, 4) 7 (16) 8= 4 (4.4) 4 (15)
School attendance 11 4 (3, 4) 7 (16) 11 4 (4, 4) 2 (7)
Parent/child global assessment of control 12 4 (3, 4) 7 (16) 14 4 (3, 4) 2 (7)
Lung function tests 13 3 (2, 3) 5 (12) 15 4 (3, 4) 1 (4)
GP/A + E attendance 14 4 (3, 4) 3 (7) 16 4 (3, 4) 0
Growth 15 4 (3, 4) 2 (5) 13 4 (3, 4) 2 (7)
Health-related problems when older 16 3 (2, 4) 0 7 4 (4, 4) 5 (19)
Short-term adverse effect 17 3 (2, 3) 0 17 4 (3, 4) 0